CLINAM 2023 brings together experts and thought leaders in nanomedicine from around the world. The event features sessions covering topics such as cancer nanomedicine, lipid nanoparticles, and immunotherapy, providing an opportunity to explore recent advancements.
Ardena will be represented by Silvie Meeuwissen, Director of Process R&D and Manufacturing for Nanomedicines, and Bastiaan Buddingh, Business Development Manager for Nanomedicines and Senior Scientist.
Bastiaan will be making a presentation on “Challenges in Clinical Development of Nanomedicines,” sharing valuable insights into this evolving field.
At Ardena, we are dedicated to advancing nanomedicine and drug development. We look forward to engaging with peers, sharing insights, and fostering collaborations that contribute to progress in healthcare.